Flavocure was founded with a focus on non-cannabinoid bioactive phytochemical properties of cannabis. The company recently discovered Creserol, a drug which recently received Orphan Drug approval by the FDA for the treatment of Acute Myeloid Leukemia. In collaboration with some of the top research institutions in the world, the company continues to embark on discoveries with the use of other drugs for the treatment pancreatic cancer and glioblastoma brain cancer. Most recently has established ongoing collaboration with Harvard Medical School and the Dana Farber Cancer Institute, as well as ongoing research with the University of Maryland Medical School and Duke University.
View Top Employees from Flavocure Biotech, Inc.| Website | http://www.flavocure.com |
| Revenue | $2 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2014 |
| Address | 701 E Pratt St, Baltimore, Maryland 21202, US |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Flavocure Biotech, Inc. employee's phone or email?
Flavocure Biotech, Inc. Questions
The Flavocure Biotech, Inc. annual revenue was $2 million in 2024.
Clark Swanson is the Co-Founder and Executive Vice Chairman of Flavocure Biotech, Inc..
3 people are employed at Flavocure Biotech, Inc..
Flavocure Biotech, Inc. is based in Baltimore, Maryland.
The NAICS codes for Flavocure Biotech, Inc. are [325, 3254, 32, 32541].
The SIC codes for Flavocure Biotech, Inc. are [28, 283].
Top Flavocure Biotech, Inc. Employees
-
45+
-
-
1
Related Companies
